1.American Brain Tumor Association, Brain Tumor Statistics.
2.Central Brain Tumor Registry of the United States, 2016 CBTRUS Fact Sheet.
3.Togao O, Hiwatashi A, Keupp J, Yamashita K, Kikuchi K, Yoshiura T, Yoneyama M, Kruiskamp MJ, Sagiyama K, Takahashi M, Honda H. Amide Proton Transfer Imaging of Diffuse Gliomas: Effect of Saturation Pulse Length in Parallel Transmission-Based Technique. PLOS ONE 2016; doi: 10.1371/journal.pone.0155925.
4. Togao O, Keupp J, Hiwatashi A, Yamashita K, Kikuchi K, Yoneyama M, Honda H. Amide Proton Transfer Imaging of Brain Tumors Using a Self-Corrected 3D Fast Spin-Echo Dixon Method: Comparison with Separate B0 correction Magn Res Med 2016 early view; doi: 10.1002/mrm.26322.
5. Togao O, Yoshiura T, Keupp J, Hiwatashi A, Yamashita K, Kikuchi K, Suzuki, YS, Iwak, T, Hata N, Mizoguchi M, Yoshimoto K, Sagiyama K, Takahashi M, Honda H Amide proton transfer imaging of adult diffuse gliomas: correlation with histopathological grades. Neuro-Oncology 2014; 16(3), 441–448.
6.Jiang S, Eberhart CG, Zhang Y, Heo HY, Wen Z, Blair L, Qin H, Lim M, Quinones- Hinojosa A6, Weingart JD, Barker PB, Pomper MG, Laterra J, van Zijl PCM, Blakeley JO, Zhou J. Amide proton transfer-weighted magnetic resonance image-guided stereotactic biopsy in patients with newly diagnosed gliomas. Eur J Cancer 201783:9-18; doi: 10.1016/j.ejca.2017.06.009.
7. Zhou, J. (2011). Amide Proton Transfer Imaging of the Human Brain. Magnetic Resonance Neuroimaging. Methods in Molecular Biology (Clifton, N.J.), 711, 227–237.
8.American Brain Tumor Association, Brain Tumor Information, Types of Tumors, Glioblastoma (GBM)
9. Lobera, A, Coobs, B, Naul, LG, Zee, CS. Imaging in Glioblastoma Multiforme. Medscape.
10.Paleologos, N. Low Grade Glioma: Update in Treatment and Care. ABTA Patient and Family Conference, 2014.
11.Upadhyay, N, Waldman, A D, Conventional MRI evaluation of gliomas. The British Journal of Radiology 2011; 84: S107–S111.
12. Wen, Z, Hu, S, Huang, F, Wang, X, Guo, L, Quan, X, Wang, S, Zhou, J, MR Imaging of High-Grade Brain Tumors Using Endogenous Protein and Peptide- Based Contrast. NeuroImage 20110; 51(2), 616–622.
13. Park KJ, Kim HS, Park JE et al. Added value of amide proton transfer imaging to conventional and perfusion MR imaging for evaluating the treatment response of newly diagnosed glioblastoma. Eur Radiol 2016, 26: 4390; doi: 10.1007/s00330- 016-4261-2.
14. Park JE, Kim HS, Park KJ, Kim SJ, Kim JH, Smith SA. Pre- and Posttreatment Glioma: Comparison of Amide Proton Transfer Imaging with MR Spectroscopy for Biomarkers of Tumor Proliferation. Radiology 2016, 278:514; doi: 10.1148/ radiol.2015142979.
15. Wang X, Yu H, Jiang S, Wang Y, Wang Y, Zhang G, Jiang C, Song G, Zhang Y, Heo H-Y, Zhou J, Wen Z. Qualitative and quantitative analysis of amide proton transferweighted MR images at 3 Tesla of adult gliomas. Abstract #1105, ISMRM 2017.
16. Miller JH, Hu HH, Pokorney A, Cornejo P, Towbin R. MRI Brain Signal Intensity Changes of a Child During the Course of 35 Gadolinium Contrast Examinations. Pediatrics 2015;136;e1637.